The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Tumour evolution in hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Self-citationGenetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Tumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9151 · Cited by 2,783
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-642_1 · Cited by 2,081
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
Hyman, D. M., Puzanov, I., Subbiah, V., Faris, J. E., Chau, I., Blay, J.-Y., Wolf, J., Raje, N. S., Diamond, E. L., Hollebecque, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502309 · Cited by 1,764
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Davoli, T., Uno, H., Wooten, E. C., & Elledge, S. J. (2017) · Science · doi:10.1126/science.aaf8399 · Cited by 1,360
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Self-citationAllele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
McGranahan, N., Rosenthal, R., Hiley, C. T., Rowan, A. J., Watkins, T. B. K., Wilson, G. A., Birkbak, N. J., Veeriah, S., Van Loo, P., Herrero, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.001 · Cited by 1,298
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Self-citationEML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Choi, Y. L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007478 · Cited by 1,189
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, D., Villanueva, A., Friedman, S. L., & Llovet, J. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,153
Self-citationSpatial and temporal diversity in genomic instability processes defines lung cancer evolution
de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., et al. (2014) · Science · doi:10.1126/science.1253462 · Cited by 1,117
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Taylor, A. M., Shih, J., Ha, G., Gao, G. F., Zhang, X., Berger, A. C., Schumacher, S. E., Wang, C., Hu, H., Liu, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.007 · Cited by 1,062
A Big Bang model of human colorectal tumor growth
Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., Marjoram, P., Siegmund, K., Press, M. F., Shibata, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3214 · Cited by 1,015
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Sia, D., Jiao, Y., Martinez-Quetglas, I., Kuchuk, O., Villacorta-Martin, C., Castro de Moura, M., Putra, J., Camprecios, G., Bassaganyas, L., Akers, N., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.007 · Cited by 976
Self-citationMerker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., Lindeman, N., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8671 · Cited by 959
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Xu, R.-H., Wei, W., Krawczyk, M., Wang, W., Luo, H., Flagg, K., Yi, S., Shi, W., Quan, Q., Li, K., et al. (2017) · Nature Materials · doi:10.1038/nmat4997 · Cited by 862
Evidence for APOBEC3B mutagenesis in multiple human cancers
Burns, M. B., Temiz, N. A., & Harris, R. S. (2013) · Nature Genetics · doi:10.1038/ng.2701 · Cited by 755
Bensch, F., van der Veen, E. L., Lub-de Hooge, M. N., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., Oosting, S. F., Schröder, C. P., Hiltermann, T. J. N., van der Wekken, A. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0255-8 · Cited by 732
The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment
Bakhoum, S. F., & Cantley, L. C. (2018) · Cell · doi:10.1016/j.cell.2018.08.027 · Cited by 717
Nault, J. C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., & Zucman-Rossi, J. (2013) · Nature Communications · doi:10.1038/ncomms3218 · Cited by 695
Hou, Y., Guo, H., Cao, C., Li, X., Hu, B., Zhu, P., Wu, X., Wen, L., Tang, F., Huang, Y., et al. (2016) · Cell Research · doi:10.1038/cr.2016.23 · Cited by 647
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., Heimbach, J. K., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.802 · Cited by 645
Decoding global gene expression programs in liver cancer by noninvasive imaging
Segal, E., Sirlin, C. B., Ooi, C., Adler, A. S., Gollub, J., Chen, X., Chan, B. K., Matcuk, G. R., Barry, C. T., Chang, H. Y., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1306 · Cited by 629
Identification of neutral tumor evolution across cancer types
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A., & Sottoriva, A. (2016) · Nature Genetics · doi:10.1038/ng.3489 · Cited by 625
Harding, J. J., Nandakumar, S., Armenia, J., Khalil, D. N., Albano, M., Ly, M., Shia, J., Hechtman, J. F., Kundra, R., El Dika, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2293 · Cited by 602
Intra-tumour diversification in colorectal cancer at the single-cell level
Roerink, S. F., Sasaki, N., Lee-Six, H., Young, M. D., Alexandrov, L. B., Behjati, S., Mitchell, T. J., Grossmann, S., Lightfoot, H., Egan, D. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0024-3 · Cited by 551
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
Tarlow, B. D., Pelz, C., Naugler, W. E., Wakefield, L., Wilson, E. M., Finegold, M. J., & Grompe, M. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.09.008 · Cited by 533
Quantitative Imaging in Cancer Evolution and Ecology
Gatenby, R. A., Grove, O., & Gillies, R. J. (2013) · Radiology · doi:10.1148/radiol.13122697 · Cited by 515
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Swanton, C., McGranahan, N., Starrett, G. J., & Harris, R. S. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0344 · Cited by 488
Evolution of Metastases in Space and Time under Immune Selection
Angelova, M., Mlecnik, B., Vasaturo, A., Bindea, G., Fredriksen, T., Lafontaine, L., Buttard, B., Morgand, E., Bruni, D., Jouret-Mourin, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.018 · Cited by 457
Villanueva, A., Hoshida, Y., Battiston, C., Tovar, V., Sia, D., Alsinet, C., Cornella, H., Liberzon, A., Kobayashi, M., Kumada, H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.006 · Cited by 447
Self-citationDNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
Villanueva, A., Portela, A., Sayols, S., Battiston, C., Hoshida, Y., Méndez‐González, J., Imbeaud, S., Letouzé, E., Hernandez‐Gea, V., Cornella, H., et al. (2015) · Hepatology · doi:10.1002/hep.27732 · Cited by 428
Self-citationTumour heterogeneity and the evolution of polyclonal drug resistance
Burrell, R. A., & Swanton, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.06.005 · Cited by 417
Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., Tessitore, A., Zazzeroni, F., & Alesse, E. (2013) · BioMed Research International · doi:10.1155/2013/187204 · Cited by 408
Necroptosis microenvironment directs lineage commitment in liver cancer
Seehawer, M., Heinzmann, F., D’Artista, L., Harbig, J., Roux, P.-F., Hoenicke, L., Dang, H., Klotz, S., Robinson, L., Doré, G., et al. (2018) · Nature · doi:10.1038/s41586-018-0519-y · Cited by 406
Nault, J.-C., Couchy, G., Balabaud, C., Morcrette, G., Caruso, S., Blanc, J.-F., Bacq, Y., Calderaro, J., Paradis, V., Ramos, J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.042 · Cited by 401
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Wolf, Y., Bartok, O., Patkar, S., Eli, G. B., Cohen, S., Litchfield, K., Levy, R., Jiménez-Sánchez, A., Trabish, S., Lee, J. S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.032 · Cited by 380
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Bernard, V., Kim, D. U., San Lucas, F. A., Castillo, J., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J., Semaan, A., Guerrero, P. A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.09.022 · Cited by 363
Nault, J. C., Calderaro, J., Di Tommaso, L., Balabaud, C., Zafrani, E. S., Bioulac‐Sage, P., Roncalli, M., & Zucman‐Rossi, J. (2014) · Hepatology · doi:10.1002/hep.27372 · Cited by 354
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
Zhang, A. W., McPherson, A., Milne, K., Kroeger, D. R., Hamilton, P. T., Miranda, A., Funnell, T., Little, N., de Souza, C. P. E., Laan, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.073 · Cited by 353
Ling, S., Hu, Z., Yang, Z., Yang, F., Li, Y., Lin, P., Chen, K., Dong, L., Cao, L., Tao, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519556112 · Cited by 352
Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Zheng, H., Pomyen, Y., Hernandez, M. O., Li, C., Livak, F., Tang, W., Dang, H., Greten, T. F., Davis, J. L., Zhao, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29778 · Cited by 349
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Zheng, R., Office for Cancer Registry, N. C. C. C. R. C. F. C. H., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., Xia, C., Yang, Z., Li, H., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.06.01 · Cited by 343
Brunt, E., Aishima, S., Clavien, P., Fowler, K., Goodman, Z., Gores, G., Gouw, A., Kagen, A., Klimstra, D., Komuta, M., et al. (2018) · Hepatology · doi:10.1002/hep.29789 · Cited by 339
Liver stem cells and hepatocellular carcinoma†
Mishra, L., Banker, T., Murray, J., Byers, S., Thenappan, A., He, A. R., Shetty, K., Johnson, L., & Reddy, E. P. (2009) · Hepatology · doi:10.1002/hep.22704 · Cited by 333
Rebouissou, S., Franconi, A., Calderaro, J., Letouzé, E., Imbeaud, S., Pilati, C., Nault, J., Couchy, G., Laurent, A., Balabaud, C., et al. (2016) · Hepatology · doi:10.1002/hep.28638 · Cited by 327
Minimal functional driver gene heterogeneity among untreated metastases
Reiter, J. G., Makohon-Moore, A. P., Gerold, J. M., Heyde, A., Attiyeh, M. A., Kohutek, Z. A., Tokheim, C. J., Brown, A., DeBlasio, R. M., Niyazov, J., et al. (2018) · Science · doi:10.1126/science.aat7171 · Cited by 307
Functional and genetic deconstruction of the cellular origin in liver cancer
Marquardt, J. U., Andersen, J. B., & Thorgeirsson, S. S. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4017 · Cited by 306
Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care
Nault, J., Bioulac–Sage, P., & Zucman–Rossi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.032 · Cited by 299
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
Morris, L. G. T., Riaz, N., Desrichard, A., Şenbabaoğlu, Y., Hakimi, A. A., Makarov, V., Reis-Filho, J. S., & Chan, T. A. (2016) · Oncotarget · doi:10.18632/oncotarget.7067 · Cited by 299
Xue, R., Chen, L., Zhang, C., Fujita, M., Li, R., Yan, S.-M., Ong, C. K., Liao, X., Gao, Q., Sasagawa, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.007 · Cited by 296
Intratumor Heterogeneity in Hepatocellular Carcinoma
Friemel, J., Rechsteiner, M., Frick, L., Böhm, F., Struckmann, K., Egger, M., Moch, H., Heikenwalder, M., & Weber, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0122 · Cited by 296
Pilati, C., Letouzé, E., Nault, J.-C., Imbeaud, S., Boulai, A., Calderaro, J., Poussin, K., Franconi, A., Couchy, G., Morcrette, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.005 · Cited by 272
Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease
Zhu, M., Lu, T., Jia, Y., Luo, X., Gopal, P., Li, L., Odewole, M., Renteria, V., Singal, A. G., Jang, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.026 · Cited by 250
Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC
Pinyol, R., Sia, D., & Llovet, J. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3778 · Cited by 249
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Gil Del Alcazar, C. R., Huh, S. J., Ekram, M. B., Trinh, A., Liu, L. L., Beca, F., Zi, X., Kwak, M., Bergholtz, H., Su, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0222 · Cited by 247
The role of telomeres and telomerase in cirrhosis and liver cancer
Nault, J.-C., Ningarhari, M., Rebouissou, S., & Zucman-Rossi, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0165-3 · Cited by 239
The Role of Telomeres in Stem Cells and Cancer
Günes, C., & Rudolph, K. L. (2013) · Cell · doi:10.1016/j.cell.2013.01.010 · Cited by 232
Kenmochi, K., Sugihara, S., & Kojiro, M. (1987) · Liver · doi:10.1111/j.1600-0676.1987.tb00310.x · Cited by 231
Jiang, P., Sun, K., Tong, Y. K., Cheng, S. H., Cheng, T. H. T., Heung, M. M. S., Wong, J., Wong, V. W. S., Chan, H. L. Y., Chan, K. C. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814616115 · Cited by 230
Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma
Lin, D.-C., Mayakonda, A., Dinh, H. Q., Huang, P., Lin, L., Liu, X., Ding, L.-W., Wang, J., Berman, B. P., Song, E.-W., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2822 · Cited by 225
Khan, K. H., Cunningham, D., Werner, B., Vlachogiannis, G., Spiteri, I., Heide, T., Mateos, J. F., Vatsiou, A., Lampis, A., Damavandi, M. D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0891 · Cited by 225
Fujimoto, A., Furuta, M., Shiraishi, Y., Gotoh, K., Kawakami, Y., Arihiro, K., Nakamura, T., Ueno, M., Ariizumi, S.-I., Hai Nguyen, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms7120 · Cited by 223
(2017) · doi:10.1158/2159-8290.cd-17-0256 · Cited by 223
Salem, M. E., Puccini, A., Grothey, A., Raghavan, D., Goldberg, R. M., Xiu, J., Korn, W. M., Weinberg, B. A., Hwang, J. J., Shields, A. F., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0735 · Cited by 217
Xue, R., Li, R., Guo, H., Guo, L., Su, Z., Ni, X., Qi, L., Zhang, T., Li, Q., Zhang, Z., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.033 · Cited by 214
Merotelic kinetochore orientation, aneuploidy, and cancer
Cimini, D. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.003 · Cited by 213
Kisiel, J. B., Dukek, B. A., V.S.R. Kanipakam, R., Ghoz, H. M., Yab, T. C., Berger, C. K., Taylor, W. R., Foote, P. H., Giama, N. H., Onyirioha, K., et al. (2019) · Hepatology · doi:10.1002/hep.30244 · Cited by 210
Tovar, V., Cornella, H., Moeini, A., Vidal, S., Hoshida, Y., Sia, D., Peix, J., Cabellos, L., Alsinet, C., Torrecilla, S., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309501 · Cited by 206
Self-citationApplications of Immunogenomics to Cancer
Liu, X. S., & Mardis, E. R. (2017) · Cell · doi:10.1016/j.cell.2017.01.014 · Cited by 205
Farazi, P. A., Glickman, J. N., Jiang, S., Yu, A., Rudolph, K. L., & DePinho, R. A. (2003) · PubMed · Cited by 201
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
Wang, D.-S., Liu, Z.-X., Lu, Y.-X., Bao, H., Wu, X., Zeng, Z.-L., Liu, Z., Zhao, Q., He, C.-Y., Lu, J.-H., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316522 · Cited by 195
Tumor Evolution as a Therapeutic Target
Amirouchene-Angelozzi, N., Swanton, C., & Bardelli, A. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0343 · Cited by 194
Torrecilla, S., Sia, D., Harrington, A. N., Zhang, Z., Cabellos, L., Cornella, H., Moeini, A., Camprecios, G., Leow, W.-Q., Fiel, M. I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.013 · Cited by 181
Self-citationRole of tumor-associated macrophages in the progression of hepatocellular carcinoma
Shirabe, K., Mano, Y., Muto, J., Matono, R., Motomura, T., Toshima, T., Takeishi, K., Uchiyama, H., Yoshizumi, T., Taketomi, A., et al. (2012) · Surgery Today · doi:10.1007/s00595-011-0058-8 · Cited by 174
Moeini, A., Sia, D., Zhang, Z., Camprecios, G., Stueck, A., Dong, H., Montal, R., Torrens, L., Martinez-Quetglas, I., Fiel, M. I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.010 · Cited by 174
Self-citationCancer-associated fibroblasts in hepatocellular carcinoma
Kubo, N., Araki, K., Kuwano, H., & Shirabe, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6841 · Cited by 173
Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution
Bakhoum, S. F., & Landau, D. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029611 · Cited by 169
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
Glickman, M. S., & Sawyers, C. L. (2012) · Cell · doi:10.1016/j.cell.2012.02.015 · Cited by 168
Jia, C., Wang, T.-T., Liu, W., Fu, B., Hua, X., Wang, G., Li, T.-J., Li, X., Wu, X.-Y., Tai, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063243 · Cited by 168
Molecular classification of hepatocellular adenoma in clinical practice
Nault, J., Paradis, V., Cherqui, D., Vilgrain, V., & Zucman‐Rossi, J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.009 · Cited by 166
Kalinich, M., Bhan, I., Kwan, T. T., Miyamoto, D. T., Javaid, S., LiCausi, J. A., Milner, J. D., Hong, X., Goyal, L., Sil, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617032114 · Cited by 164
Um, T.-H., Kim, H., Oh, B.-K., Kim, M. S., Kim, K. S., Jung, G., & Park, Y. N. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.021 · Cited by 159
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
Janiszewska, M., Tabassum, D. P., Castaño, Z., Cristea, S., Yamamoto, K. N., Kingston, N. L., Murphy, K. C., Shu, S., Harper, N. W., Del Alcazar, C. G., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0346-x · Cited by 159
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Castelli, G., Pelosi, E., & Testa, U. (2017) · Cancers · doi:10.3390/cancers9090127 · Cited by 158
Duan, M., Hao, J., Cui, S., Worthley, D. L., Zhang, S., Wang, Z., Shi, J., Liu, L., Wang, X., Ke, A., et al. (2018) · Cell Research · doi:10.1038/cr.2018.11 · Cited by 158
Zhai, W., Lim, T. K. H., Zhang, T., Phang, S.-T., Tiang, Z., Guan, P., Ng, M.-H., Lim, J. Q., Yao, F., Li, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14565 · Cited by 151
Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
Nishida, N., & Kudo, M. (2016) · Oncology · doi:10.1159/000451015 · Cited by 142
Koeberle, D., Dufour, J., Demeter, G., Li, Q., Ribi, K., Samaras, P., Saletti, P., Roth, A., Horber, D., Bühlmann, M., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw054 · Cited by 136
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
Cazals-Hatem, D. L., Rebouissou, S., Bioulac‐Sage, P., Bluteau, O., Blanché, H., Franco, D., Monges, G. M., Belghiti, J., Cunha, A. S., Laurent‐Puig, P., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.04.030 · Cited by 135
Karagonlar, Z. F., Koç, D., İşcan, E., Erdal, E., & Atabey, N. (2016) · Cancer Science · doi:10.1111/cas.12891 · Cited by 135
Chen, Y., Wong, P. P., Sjeklocha, L. M., Steer, C. J., & Sahin, B. M. (2011) · Hepatology · doi:10.1002/hep.24712 · Cited by 133
Stavraka, C., Rush, H. L., & Ross, P. J. (2018) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s159805 · Cited by 132
Joseph, N. M., Tsokos, C. G., Umetsu, S. E., Shain, A. H., Kelley, R. K., Onodera, C. S., Bowman, S., Talevich, E., Ferrell, L. D., Kakar, S., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5243 · Cited by 132
Ogle, L. F., Orr, J. G., Willoughby, C. E., Hutton, C., McPherson, S., Plummer, R., Boddy, A. V., Curtin, N. J., Jamieson, D., & Reeves, H. L. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.014 · Cited by 130
Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution
Laughney, A. M., Elizalde, S., Genovese, G., & Bakhoum, S. F. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.065 · Cited by 124
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
Iavarone, M. A., Piscaglia, F., Vavassori, S., Galassi, M., Sangiovanni, A., Venerandi, L., Forzenigo, L. V., Golfieri, R., Bolondi, L., & Colombo, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.013 · Cited by 124
Labgaa, I., Villacorta-Martín, C., D’Avola, D., Craig, A. J., von Felden, J., Martins-Filho, S. N., Sia, D., Stueck, A., Ward, S. C., Fiel, M. I., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0206-3 · Cited by 121
Self-citationHuang, A., Zhang, X., Zhou, S., Cao, Y., Huang, X., Fan, J., Yang, X., & Zhou, J. (2016) · Journal of Cancer · doi:10.7150/jca.15823 · Cited by 120
Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection
Vermehren, J., Park, J. S., Jacobson, I. M., & Zeuzem, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.002 · Cited by 118
The immune system profoundly restricts intratumor genetic heterogeneity
Milo, I., Bedora-Faure, M., Garcia, Z., Thibaut, R., Perié, L., Shakhar, G., Deriano, L., & Bousso, P. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1435 · Cited by 116
Raynaud, F., Mina, M., Tavernari, D., & Ciriello, G. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007669 · Cited by 109
Furuta, M., Ueno, M., Fujimoto, A., Hayami, S., Yasukawa, S., Kojima, F., Arihiro, K., Kawakami, Y., Wardell, C. P., Shiraishi, Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.021 · Cited by 108
Intratumor heterogeneity predicts metastasis of triple-negative breast cancer
Yang, F., Wang, Y., Li, Q., Cao, L., Sun, Z., Jin, J., Fang, H., Zhu, A., Li, Y., Zhang, W., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx071 · Cited by 98
Xu, R., Zhang, X., Zhang, W., Fang, Y., Zheng, S. S., & Yu, X.-F. (2007) · Hepatology · doi:10.1002/hep.21893 · Cited by 97
Hectors, S. J. C. G., Wagner, M., Bane, O., Besa, C., Lewis, S. C., Remark, R., Chen, N., Fiel, M. I., Zhu, H., Gnjatic, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02706-z · Cited by 96
Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
Wang, A., Wu, L., Lin, J., Han, L., Bian, J., Wu, Y., Robson, S. C., Xue, L., Ge, Y., Sang, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03276-y · Cited by 96
Song, T., Dou, C., Jia, Y., Tu, K., & Zheng, X. M. (2015) · Oncotarget · doi:10.18632/oncotarget.3616 · Cited by 92
D’Avola, D., Villacorta-Martín, C., Martins-Filho, S. N., Craig, A. J., Labgaa, I., von Felden, J., Allette, K., Bonaccorso, A., Tabrizian, P., Hartmann, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30047-y · Cited by 90
Self-citationIntratumor Molecular and Phenotypic Diversity in Hepatocellular Carcinoma
Nault, J., & Villanueva, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2602 · Cited by 89
Self-citationvon Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S., & Wege, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21208 · Cited by 88
Cai, Z., Chen, G., Zeng, Y., Dong, X., Lin, M., HUANG, X.-H., Zhang, D., Liu, X., & Liu, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30798 · Cited by 84
Buczak, K., Ori, A., Kirkpatrick, J. M., Holzer, K., Dauch, D., Roessler, S., Endris, V., Lasitschka, F., Parca, L., Schmidt, A., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000189 · Cited by 79
Liu, Z., Lian, B., Dong, Q., Sun, H., Wei, J., Sheng, Y., Li, W., Li, Y., Xie, L., Liu, L., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.027 · Cited by 76
Trends in Liver Cancer Mortality Among Adults Aged 25 and Over in the United States, 2000-2016.
Xu, J. (2018) · PubMed · Cited by 74
Dazert, E., Colombi, M., Boldanova, T., Moes, S., Adametz, D., Quagliata, L., Röth, V., Terracciano, L., Heim, M. H., Jenoe, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523434113 · Cited by 73
Augmentation of metastasis formation by thioglycollate‐elicited macrophages
Gorelik, E., Wiltrout, R. H., Brunda, M. J., Holden, H. T., & Herberman, R. B. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290514 · Cited by 72
Xia, W., Chen, Y., Zhang, R., Yan, Z., Zhou, X., Zhang, B., & Gao, X. (2018) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aaa609 · Cited by 66
Liquid biopsy in liver cancer.
Labgaa, I., & Villanueva, A. (2015) · PubMed · Cited by 59
Self-citationAdvanced precancerous lesions in the liver
Tommaso, L. D., Sangiovanni, A., Borzio, M., Park, Y. N., Farinati, F., & Roncalli, M. G. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.015 · Cited by 57
Shi, L., Zhang, Y., Feng, L., Wang, L., Rong, W., Wu, F., Wu, J., Zhang, K., & Cheng, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16758 · Cited by 45
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity
Shi, J.-Y., Xing, Q., Duan, M., Wang, Z., Yang, L., Zhao, Y., Wang, X.-Y., Liu, Y., Deng, M., Ding, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6558 · Cited by 44
Ovarian Cancer Stem Cell Heterogeneity
Hatina, J., Boesch, M., Sopper, S., Kripnerová, M., Wolf, D. G. F., Reimer, D., Marth, C., & Zeimet, A. G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_12 · Cited by 43
He, J., Gerstenlauer, M., Chan, L. K., Leithäuser, F., Yeh, M. M., Wirth, T., & Maier, H. J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.023 · Cited by 34
Bioulac‐Sage, P., Sempoux, C. L., & Balabaud, C. P. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.01.003 · Cited by 33
Heterogeneity in Colorectal Cancer Stem Cells
Hirata, A., Hatano, Y., Niwa, M., Hara, A., & Tomita, H. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0482 · Cited by 33
A comparison of four epidemiological methods of assessing periodontal disease
Sheiham, A., & Striffler, D. F. (1970) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1970.tb00708.x · Cited by 26
JEON, J., Maeng, L.-S., Bae, Y. J., Lee, E. J., Yoon, Y. C., & Yoon, N. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20087 · Cited by 18
Yang, Z., Lu, Y., Xu, Q., Zhuang, L., Tang, B., & Chen, X. (2015) · Europe PMC (PubMed Central) · Cited by 16
Martins-Filho, S. N., Alves, V. A. F., Wakamatsu, A., Maeda, M., Craig, A. J., Assato, A. K., Villacorta-Martín, C., D’Avola, D., Labgaa, I., Carrilho, F. J., et al. (2019) · Histopathology · doi:10.1111/his.13809 · Cited by 11
Self-citationHu, G., Zhang, Y., Ouyang, K., Xie, F., Fang, H., Yang, X., Liu, K., Wang, Z., Tang, X., Liu, J., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9078 · Cited by 10
Cited by
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.985363 · Cited by 1,011
“Hepatocellular carcinoma (HCC) is the second largest cancer-related death (112); the 5-year survival rate is only 18% (113), characterized by high mortality, strong invasiveness, low sensitivity to chemotherapy drugs, and easy resistance (114).”
BackgroundTargeted therapy for hepatocellular carcinoma
Huang, A., Yang, X.-R., Chung, W.-Y., Dennison, A. R., & Zhou, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00264-x · Cited by 739
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
Lee, T. K.-W., Guan, X.-Y., & Ma, S. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00508-3 · Cited by 460
Zhao, Y., Li, M., Yao, X., Fei, Y., Lin, Z., Li, Z., Cai, K., Zhao, Y., & Luo, Z. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108487 · Cited by 412
Comprehensive analysis of spatial architecture in primary liver cancer
Wu, R., Guo, W., Qiu, X., Wang, S., Sui, C., Lian, Q., Wu, J., Shan, Y., Yang, Z., Yang, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3750 · Cited by 369
Metadata
- Authors
- Craig, A. J., von Felden, J., Garcia-Lezana, T., Sarcognato, S., & Villanueva, A.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-12-02
- Volume
- 17
- Issue
- 3
- Pages
- 139-152
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2990323558
- Cited by
- 823
- References
- 162
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.